Sight Sciences (SGHT) Asset Writedowns and Impairment (2020 - 2026)
Sight Sciences (SGHT) posted quarterly Asset Writedowns and Impairment of -$28000.0 for Q1 2026, down 180.0% year-over-year from $35000.0 in Q1 2025, and down 127.72% quarter-over-quarter from $101000.0 in Q4 2025.
Sight Sciences (SGHT) Asset Writedowns and Impairment (2020 - 2026) Analysis & Trends
Sight Sciences' Asset Writedowns and Impairment history runs 7 years deep, the most recent figure standing at -$28000.0 for Q1 2026.
- In Q1 2026, Asset Writedowns and Impairment fell 180.0% year-over-year to -$28000.0; the TTM figure through Mar 2026 stood at $66000.0 (up 266.67% YoY), while the FY2025 annual figure was $129000.0, up 407.14% from the prior year.
- Asset Writedowns and Impairment for Q1 2026 stood at -$28000.0, down from $101000.0 in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $458000.0 in Q2 2023, with the low at -$250000.0 in Q1 2023.
- The 5-year median for Asset Writedowns and Impairment is $26000.0 (2025), against an average of $51705.9.
- The sharpest annual moves came in 2023 and 2024: Asset Writedowns and Impairment sank 3225.0% in 2023, then surged 3050.0% in 2024.
- Sight Sciences' Asset Writedowns and Impairment stood at $7000.0 in 2022, then sank by 71.43% to $2000.0 in 2023, then soared by 3050.0% to $63000.0 in 2024, then soared by 60.32% to $101000.0 in 2025, then tumbled by 127.72% to -$28000.0 in 2026.
- Business Quant data shows SGHT's Asset Writedowns and Impairment at -$28000.0 in Q1 2026, $101000.0 in Q4 2025, and -$33000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Sight Sciences | 449.13 Mn | 369.37 Mn | 21.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28,000.00 |
| Mar 31, 2026 | -28,000.00 |
| Dec 31, 2025 | 101,000.00 |
| Dec 31, 2025 | 101,000.00 |
| Sep 30, 2025 | -33,000.00 |
| Sep 30, 2025 | -33,000.00 |
| Jun 30, 2025 | 26,000.00 |
| Jun 30, 2025 | 26,000.00 |
| Mar 31, 2025 | 35,000.00 |
| Mar 31, 2025 | 35,000.00 |
| Dec 31, 2024 | 63,000.00 |
| Dec 31, 2024 | 63,000.00 |
| Sep 30, 2024 | -209,000.00 |
| Sep 30, 2024 | -209,000.00 |
| Jun 30, 2024 | 129,000.00 |
| Jun 30, 2024 | 129,000.00 |
| Mar 31, 2024 | -25,000.00 |
| Mar 31, 2024 | -25,000.00 |
| Dec 31, 2023 | 2,000.00 |
| Dec 31, 2023 | 2,000.00 |